Enzamale 40 (Enzalutamide)

Enzamale 40mg tablet contains the active ingredient enzalutamide. It is an antineoplastic drug that belongs to the category of medicines known as androgen receptor inhibitors. This medication is used in the treatment of advanced prostate cancer in patients who do not respond to surgical or hormonal treatments. 

 It is not recommended to take nzalut 40mg tablet if you are allergic to enzalutamide or any of its ingredients. During the Enzamale 40mg tablet treatment, your doctor may periodically monitor for Prostate-specific antigen (PSA) tests. This blood test measures the level of PSA, a protein produced by the prostate gland that can be elevated in men with prostate cancer. PSA levels can help monitor the progression of the disease and the response to treatment. Other tests also include liver function tests and complete blood count(CBC) to prevent serious complications.

 This medicine can cause seizures, so patients with a history of seizures should use caution when taking this medication. Avoid grapefruit and grapefruit juice while taking Enzamale 40mg tablet, as it can increase the levels of the medication in the body. This drug is not recommended during pregnancy as it causes harm to the unborn baby, and it also causes fertility issues, inform your doctor about any fertility concern you may have before starting treatment with this medicine. Before beginning this treatment, tell your healthcare provider if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and for 3 months after the last dose of Enzamale 40mg tablet.